跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 49 条关于
“tengotinib”
全部
49
临床试验
39
药物
2
机构
0
资讯
8
前天
Allist's Jetientai (tengotinib) included in CSCO diagnosis and treatment guidelines
去年
FDA Approves FoundationOne Liquid CDx as Companion Diagnostic for Tepotinib in METex14-Skipping NSCLC
9个月前
TransThera's Tinengotinib Receives Priority Review Status in China for Advanced Cholangiocarcinoma Treatment
去年
FDA Approves Companion Diagnostic for Tepotinib in mNSCLC with MET Exon 14 Skipping Alterations
去年
TransThera's Tinengotinib Shows Promise Against FGFR-Resistant Cholangiocarcinoma in Annals of Oncology Study
去年
FDA Approves FoundationOne Liquid CDx as Companion Diagnostic for Tepotinib in NSCLC
4个月前
FDA Approves FoundationOne CDx as Companion Diagnostic for Tepotinib in MET Exon 14-Positive NSCLC
去年
Tepotinib Shows High Frequency of Adverse Events but Manageable Safety Profile in MET Exon 14-Altered NSCLC